Exhibit 10.18




 


 


THIS WARRANT AND THE SHARES OF COMMON
STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933 (THE “SECURITIES ACT”) OR UNDER ANY STATE SECURITIES LAWS (“BLUE SKY LAWS”). NO TRANSFER, SALE, ASSIGNMENT,
PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SECURITIES OR ANY INTEREST THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE BLUE SKY LAWS OR (B) IF THE COMPANY HAS BEEN FURNISHED
WITH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL WILL BE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT
THAT NO REGISTRATION IS REQUIRED BECAUSE OF THE AVAILABILITY OF AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE
BLUE SKY LAWS.


 


SERIES B
PLACEMENT AGENT WARRANT


 


To Purchase ____________
Shares of Common Stock


of


FUSE SCIENCE, INC.


 


EXERCISABLE ON OR BEFORE,
AND VOID AFTER


5:00 P.M. EASTERN TIME
ON SEPTEMBER 9, 2012


 


THIS CERTIFIES THAT,
for good and valuable consideration, ___________________ (“Holder”), or its registered assigns, is entitled
to subscribe for and purchase from FUSE SCIENCE, INC., a Nevada corporation (the “Company”), at any time after
February 9, 2012, to and including September 9, 2012, _______________________________ (________) fully paid and non-assessable
shares of the common stock of the Company (“Shares”) at the price of $0.21 per Share (the “Warrant
Exercise Price”), subject to adjustment pursuant to the anti-dilution provisions of this Warrant.


 


The Shares that may
be acquired upon exercise of this Warrant are sometimes referred to herein as the “Warrant Shares.” As used
herein, the term “Holder” includes any party who acquires all or a part of this Warrant as a registered transferee
of Holder, or any record holder or holders of the Warrant Shares issued upon exercise, whether in whole or in part, of the Warrant.
The term “Shares” means the common stock, par value $0.001 per share, of the Company, and will also include
any capital stock of any class of the Company hereafter authorized which will not be limited to a fixed sum or percentage in respect
of the rights of the holders thereof to participate in dividends or in the distribution of assets upon the voluntary or involuntary
liquidation, dissolution, or winding up of the Company. The term “Convertible Securities” means any stock or
other securities convertible into, or exchangeable for, Shares.


 






    	



    	 



    
 


This Warrant is subject
to the following provisions, terms and conditions:


 


1.Exercise.
The rights represented by this Warrant may be exercised by the Holder hereof, in whole or in part (but not as to a fractional Share),
by written notice of exercise (in the form attached hereto) delivered to the Company at the principal office of the Company prior
to the expiration of this Warrant and accompanied or preceded by the surrender of this Warrant along with a check in payment of
the Warrant Exercise Price for such shares.


 


2.Exchange
and Replacement. Subject to Sections 1 and 7 hereof, this Warrant is exchangeable upon the surrender hereof
by the Holder to the Company at its office for new Warrants of like tenor and date representing in the aggregate the right to purchase
the number of Warrant Shares purchasable hereunder, each of such new Warrants to represent the right to purchase such number of
Warrant Shares (not to exceed the aggregate total number purchasable hereunder) as will be designated by the Holder at the time
of such surrender. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction, or mutilation
of this Warrant, and, in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor, in lieu of this
Warrant. This Warrant will be promptly canceled by the Company upon the surrender hereof in connection with any exchange or replacement.
The Company will pay all expenses, taxes (other than stock transfer taxes), and other charges payable in connection with the preparation,
execution, and delivery of Warrants pursuant to this Section 2.


 


3.Issuance
of the Warrant Shares.


 


(a)The Company
agrees that the Warrant Shares purchased upon exercise of this Warrant will be and are deemed to be issued to the Holder as of
the close of business on the date on which this Warrant will have been surrendered and the payment made for such Warrant Shares
as aforesaid. Subject to the provisions of paragraph (b) of this Section 3, certificates for the Warrant Shares so purchased
will be delivered to the Holder within a reasonable time, not exceeding fifteen (15) days after the rights represented by this
Warrant will have been so exercised, and, unless this Warrant has expired, a new Warrant representing the right to purchase the
number of Warrant Shares, if any, with respect to which this Warrant will not then have been exercised will also be delivered to
the Holder within such time.


 


(b)Nothing
set forth in this Warrant (including without limitation the registration rights set forth in Section 7), shall require the
Company (i) to deliver any certificate for Warrant Shares upon exercise of this Warrant except in accordance with registration
under or exemptions from the applicable securities registration requirements under the Securities Act or applicable Blue Sky Laws
or (ii) obligate the Company to effect registrations under the Securities Act or applicable Blue Sky Laws covering the initial
issuance of the Warrant Shares upon exercise of the Warrants. The Holder agrees to execute such documents and make such representations,
warranties, and agreements as may be required solely to comply with the exemptions reasonably relied upon by the Company for the
issuance of the Warrant Shares without registration upon exercise of this Warrant.


 


4.Covenants
of the Company. The Company covenants and agrees that all Warrant Shares will, upon issuance, be duly authorized and issued,
fully paid, non-assessable and free from all taxes, liens and charges with respect to the issue thereof. The Company further covenants
and agrees that during the period within which the rights represented by this Warrant may be exercised, the Company will at all
times have authorized and reserved for the purpose of issue or transfer upon exercise of the subscription rights evidenced by this
Warrant a sufficient number of Shares to provide for the exercise of the rights represented by this Warrant.


  



    	2



    	 



    



 


5.Anti-Dilution
Adjustments. The provisions of this Warrant are subject to adjustment as provided in this Section 5.


 


(a)The Warrant
Exercise Price will be adjusted from time to time such that in case the Company will hereafter:


 


(i)pay any dividends
on any class of stock of the Company payable in Shares or Convertible Securities;


 


(ii)subdivide its then
outstanding Shares into a greater number of Shares; or


 


(iii)combine outstanding
Shares by reclassification or otherwise;


 


then, in any such event,
the Warrant Exercise Price in effect immediately prior to such event will (until adjusted again pursuant hereto) be adjusted immediately
after such event to a price (calculated to the nearest full cent) determined by dividing (A) the number of Shares outstanding immediately
prior to such event, multiplied by the then existing Warrant Exercise Price, by (B) the total number of Shares outstanding immediately
after such event (including in each case the maximum number of Shares issuable in respect of any Convertible Securities), and the
resulting quotient will be the adjusted Warrant Exercise Price per share. An adjustment made pursuant to this Section 5
will become effective immediately after the record date in the case of a dividend or distribution and will become effective immediately
after the effective date in the case of a subdivision, combination or reclassification. If, as a result of an adjustment made pursuant
to this Section 5, the Holder of any Warrant thereafter surrendered for exercise will become entitled to receive shares
of two or more classes of capital stock and other capital stock of the Company, the Board of Directors (whose determination will
be conclusive) will determine the allocation of the adjusted Warrant Exercise Price between or among shares of such classes of
capital stock. All calculations under this Section 5(a) will be made to the nearest cent or to the nearest 1/100 of a share,
as the case may be. In the event that at any time as a result of an adjustment made pursuant to this Section 5(a), the holder
of any Warrant thereafter surrendered for exercise will become entitled to receive any shares of capital stock of the Company other
than Shares, thereafter the Warrant Exercise Price of such other shares so receivable upon exercise of any Warrant will be subject
to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to
Shares contained in this Section 5.


 


(b)Upon each
adjustment of the Warrant Exercise Price pursuant to Section 5(a), the Holder of each Warrant will thereafter (until
another such adjustment) be entitled to purchase at the adjusted Warrant Exercise Price the number of shares, calculated to the
nearest full share, obtained by multiplying the number of shares specified in such Warrant (as adjusted as a result of all adjustments
in the Warrant Exercise Price in effect prior to such adjustment) by the Warrant Exercise Price in effect prior to such adjustment
and dividing the product so obtained by the adjusted Warrant Exercise Price.


 






    	3



    	 



    
 


(c)In case
of any consolidation or merger to which the Company is a party other than a merger or consolidation in which the Company is the
continuing corporation, or in case of any sale or conveyance to another corporation of the property of the Company as an entirety
or substantially as an entirety, or in the case of any statutory exchange of securities with another corporation (including any
exchange effected in connection with a merger of a third corporation into the Company), there will be no adjustment under Section
5(a) above but the Holder of each Warrant then outstanding will have the right thereafter to convert such Warrant into the
kind and amount of shares of capital stock and other securities and property which he would have owned or have been entitled to
receive immediately after such consolidation, merger, statutory exchange, sale, or conveyance had such Warrant been converted immediately
prior to the effective date of such consolidation, merger, statutory exchange, sale, or conveyance and in any such case, if necessary,
appropriate adjustment will be made in the application of the provisions set forth in this Section 5 with respect to the
rights and interests thereafter of any Holders of the Warrant, to the end that the provisions set forth in this Section 5
will thereafter correspondingly be made applicable, as nearly as may reasonably be, in relation to any shares of stock and other
securities and property thereafter deliverable on the exercise of the Warrant. The provisions of this Section 5(c) will
similarly apply to successive consolidations, mergers, statutory exchanges, sales or conveyances.


 


(d)In addition
to the anti-dilution adjustments provided elsewhere in this Section 5, in the event an adjustment is made to the Warrant
Exercise Price of and number of Warrant Shares issuable pursuant to those certain Series B Warrants issued by the Company in a
private transaction exempt from the registration requirements of the Securities Act on February 9, 2012, then a comparable
adjustment shall be made to the Warrant Exercise Price of and number of Warrant Shares issuable pursuant to this Warrant.


 


(e)Upon any
adjustment of the Warrant Exercise Price, then and in each such case, the Company will give written notice thereof, by first-class
mail, postage prepaid, addressed to the Holder as shown on the books of the Company, which notice will state the Warrant Exercise
Price resulting from such adjustment and the increase or decrease, if any, in the number of Shares purchasable at such price upon
the exercise of this Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation
is based.


 


6.No
Voting Rights. This Warrant will not entitle the Holder to any voting rights or other rights as a shareholder of the Company.


 


7.Registration
Rights. In satisfaction of the piggyback registration rights provided in that certain Investment Banking Agreement dated
August 2, 2011 by and between National Securities Corporation and the Company, the Warrant Shares will be included in any registration
statement filed pursuant to a certain Registration Rights Agreement, dated as of the date hereof, by and among the Company and
the initial holders of the securities covered by the Registration Rights Agreement and Holder will have substantially the same
rights relating to the resale of the Warrant Shares (including the right to require the Company to maintain the effectiveness of
any registration statement covering the Warrant Shares) as those afforded a “Buyer” pursuant to the Registration
Rights Agreement.


 






    	4



    	 



    
 


8.Notice
of Transfer of Warrant or Resale of the Warrant Shares. Holder, by acceptance hereof, agrees to give written notice to
the Company before transferring this Warrant or transferring any Warrant Shares of such Holder’s intention to do so, describing
briefly the manner of any proposed transfer. Holder shall also furnish the Company with an opinion of counsel reasonably acceptable
to it to the effect that promptly upon receiving such written notice, the Company will present copies thereof to counsel to the
original purchaser of this Warrant. The proposed transfer may be effected without registration under the Securities Act or applicable
Blue Sky Laws. The prospective transferee or purchaser will also execute such documents and make such representations, warranties,
and agreements as may be required solely to comply with the exemptions relied upon by the Company for the transfer or disposition
of the Warrant or Warrant Shares.


 


9.Fractional
Shares. Fractional shares will not be issued upon the exercise of this Warrant, but in any case where the holder would,
except for the provisions of this Section, be entitled under the terms hereof to receive a fractional share, the number of Shares
will be rounded up to the nearest whole Share.


 


10.Governing
Law. This Warrant shall be governed by the laws of the State of Nevada.


 


IN WITNESS WHEREOF,
the Company has caused this Warrant to be signed by its duly authorized officer and this Warrant to be dated as of February 9,
2012


 


FUSE SCIENCE,
INC.


 





By: /s/ Brian Tuffin                        


Name: Brian Tuffin


Title: CEO





 



    	5



    	 



    





 


SUBSCRIPTION FORM


(To be signed upon
exercise of Series B Placement Agent Warrant)


 


The undersigned, the
holder of the within Series B Placement Agent Warrant (the “Warrant”), hereby irrevocably elects to exercise
the purchase right represented by the Warrant for, and to purchase thereunder, ____________ _________________ of the shares of
common stock of Fuse Science, Inc., a Nevada corporation, to which the Warrant relates and herewith makes payment of $__________________
therefore in cash or by certified check and requests that the certificate for such shares be issued in the name of, and be delivered
to, ______________________, the address for which is set forth below the signature of the undersigned.


 


Dated: __________________


 


____________________________________


(Signature)


 


____________________________________


(Name)


 


____________________________________


(Address)


 


____________________________________


Social Security
or Tax Identification Number


 


 



    	6



    	 



    
 


ASSIGNMENT FORM


(To be signed upon
authorized transfer of Series B Placement Agent Warrant)


 


FOR VALUE RECEIVED,
the undersigned hereby sells, assigns, and transfers unto ______________________________ the right to purchase ____________ shares
of common stock of Fuse Science, Inc., a Nevada corporation (the “Company”) to which the within Series B Placement
Agent Warrant relates and appoints ___________________ attorney, to transfer said right on the books of the Company with full power
of substitution in the premises.


 


Dated: __________________


 


____________________________________


(Signature)


 


____________________________________


(Name)


 


____________________________________


(Address)


 


____________________________________


Social Security
or Tax Identification Number


 



    	7